
Erin M. Bowers
Examiner (ID: 17016, Phone: (571)272-2897 , Office: P/1653 )
| Most Active Art Unit | 1653 |
| Art Unit(s) | 1653 |
| Total Applications | 702 |
| Issued Applications | 320 |
| Pending Applications | 113 |
| Abandoned Applications | 288 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18215297
[patent_doc_number] => 11590211
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Systems for treating dermal inflammatory conditions
[patent_app_type] => utility
[patent_app_number] => 17/068722
[patent_app_country] => US
[patent_app_date] => 2020-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5299
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17068722
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/068722 | Systems for treating dermal inflammatory conditions | Oct 11, 2020 | Issued |
Array
(
[id] => 18107207
[patent_doc_number] => 20230000087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => ENDOPHYTIC STRAIN OF CLONOSTACHYS ROSEA FOR BIOCONTROL OF PHYTOPATHOGENIC FUNGI
[patent_app_type] => utility
[patent_app_number] => 17/757206
[patent_app_country] => US
[patent_app_date] => 2020-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17757206
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/757206 | ENDOPHYTIC STRAIN OF CLONOSTACHYS ROSEA FOR BIOCONTROL OF PHYTOPATHOGENIC FUNGI | Sep 15, 2020 | Abandoned |
Array
(
[id] => 16749937
[patent_doc_number] => 20210101946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => HIGH MOLECULAR WEIGHT SILK FIBROIN AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/998966
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16998966
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/998966 | HIGH MOLECULAR WEIGHT SILK FIBROIN AND USES THEREOF | Aug 19, 2020 | Pending |
Array
(
[id] => 16627512
[patent_doc_number] => 20210046165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza Patients
[patent_app_type] => utility
[patent_app_number] => 16/945776
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16945776
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/945776 | Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza Patients | Jul 30, 2020 | Abandoned |
Array
(
[id] => 20865589
[patent_doc_number] => 12692467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-28
[patent_title] => High-throughput magnetic actuation platform for cancer treatment screening
[patent_app_type] => utility
[patent_app_number] => 16/936119
[patent_app_country] => US
[patent_app_date] => 2020-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 45
[patent_no_of_words] => 4397
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936119
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/936119 | HIGH-THROUGHPUT MAGNETIC ACTUATION PLATFORM FOR CANCER TREATMENT SCREENING | Jul 21, 2020 | Issued |
Array
(
[id] => 16613759
[patent_doc_number] => 20210032412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => ELECTROCHEMICALLY ENGINEERED SURFACE OF HYDROGELS, PARTICULARLY PEG HYDROGELS, FOR ENHANCED CELLULAR PENETRATION
[patent_app_type] => utility
[patent_app_number] => 16/931452
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9645
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16931452
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/931452 | Electrochemically engineered surface of hydrogels, particularly peg hydrogels, for enhanced cellular penetration | Jul 16, 2020 | Issued |
Array
(
[id] => 19651280
[patent_doc_number] => 12173049
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Cell culture medium
[patent_app_type] => utility
[patent_app_number] => 16/906766
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 24
[patent_no_of_words] => 21353
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16906766
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/906766 | Cell culture medium | Jun 18, 2020 | Issued |
Array
(
[id] => 17913486
[patent_doc_number] => 20220315881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => RECOMBINANT FUNGAL STRAINS WITH REDUCED LEVELS OF MYCOTOXINS
[patent_app_type] => utility
[patent_app_number] => 17/614710
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614710
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614710 | RECOMBINANT FUNGAL STRAINS WITH REDUCED LEVELS OF MYCOTOXINS | May 28, 2020 | Abandoned |
Array
(
[id] => 19855723
[patent_doc_number] => 12258547
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-25
[patent_title] => Cell culture plate, method for preparing thereof and method for detecting a substance
[patent_app_type] => utility
[patent_app_number] => 16/878044
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 32
[patent_no_of_words] => 29015
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878044
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/878044 | Cell culture plate, method for preparing thereof and method for detecting a substance | May 18, 2020 | Issued |
Array
(
[id] => 19241060
[patent_doc_number] => 12011476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-18
[patent_title] => Treatments of oxidative stress conditions
[patent_app_type] => utility
[patent_app_number] => 15/931809
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 68
[patent_no_of_words] => 24842
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931809
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/931809 | Treatments of oxidative stress conditions | May 13, 2020 | Issued |
Array
(
[id] => 17442401
[patent_doc_number] => 20220062906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => DEVICE FOR DETECTING ORGANOPHOSPHATES
[patent_app_type] => utility
[patent_app_number] => 17/609376
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609376
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609376 | Device for detecting organophosphates | May 5, 2020 | Issued |
Array
(
[id] => 16710389
[patent_doc_number] => 20210077536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => NON-NATURALLY OCCURING THREE-DIMENSIONAL (3D) BROWN ADIPOSE-DERIVED STEM CELL AGGREGATES, AND METHODS OF GENERATING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/862226
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16862226
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/862226 | NON-NATURALLY OCCURING THREE-DIMENSIONAL (3D) BROWN ADIPOSE-DERIVED STEM CELL AGGREGATES, AND METHODS OF GENERATING AND USING THE SAME | Apr 28, 2020 | Abandoned |
Array
(
[id] => 16376598
[patent_doc_number] => 20200325440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => BACTERIAL STRAINS CAPABLE OF METABOLIZING OXALATES
[patent_app_type] => utility
[patent_app_number] => 16/861136
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16861136
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/861136 | BACTERIAL STRAINS CAPABLE OF METABOLIZING OXALATES | Apr 27, 2020 | Abandoned |
Array
(
[id] => 16252137
[patent_doc_number] => 20200261511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => LYMPHOCYTE BIOMARKERS FOR DETERMINING THE CLINICAL RESPONSE TO CELL THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/854294
[patent_app_country] => US
[patent_app_date] => 2020-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16854294
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/854294 | Lymphocyte biomarkers for determining the clinical response to cell therapy | Apr 20, 2020 | Issued |
Array
(
[id] => 16204893
[patent_doc_number] => 20200237883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => STABLE FORMULATIONS FOR CNS DELIVERY OF ARYLSULFATASE A
[patent_app_type] => utility
[patent_app_number] => 16/851822
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16851822
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/851822 | STABLE FORMULATIONS FOR CNS DELIVERY OF ARYLSULFATASE A | Apr 16, 2020 | Abandoned |
Array
(
[id] => 16204976
[patent_doc_number] => 20200237966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => Quenched coating
[patent_app_type] => utility
[patent_app_number] => 16/850034
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16850034
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/850034 | Quenched coating | Apr 15, 2020 | Issued |
Array
(
[id] => 16853529
[patent_doc_number] => 20210154274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME FOR ASSESSING AND/OR TREATING PERIORBITAL PUFFINESS
[patent_app_type] => utility
[patent_app_number] => 16/840250
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840250
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/840250 | Hyaluronidase compositions and methods of using same for assessing and/or treating periorbital puffiness | Apr 2, 2020 | Issued |
Array
(
[id] => 17655395
[patent_doc_number] => 20220175860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => DUNALIELLA ALGA PREPARATION FOR PREVENTION AND/OR TREATMENT OF A NEURODEGENERATIVE DISEASE, A DISORDER ASSOCIATED WITH PROTEIN MISFOLDING AND COGNITIVE DECLINE
[patent_app_type] => utility
[patent_app_number] => 17/594084
[patent_app_country] => US
[patent_app_date] => 2020-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594084
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594084 | DUNALIELLA ALGA PREPARATION FOR PREVENTION AND/OR TREATMENT OF A NEURODEGENERATIVE DISEASE, A DISORDER ASSOCIATED WITH PROTEIN MISFOLDING AND COGNITIVE DECLINE | Mar 31, 2020 | Pending |
Array
(
[id] => 16539412
[patent_doc_number] => 20200405825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => Methods and Compositions for CNS Delivery of Arylsulfatase A
[patent_app_type] => utility
[patent_app_number] => 16/828731
[patent_app_country] => US
[patent_app_date] => 2020-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16828731
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/828731 | Methods and compositions for CNS delivery of arylsulfatase A | Mar 23, 2020 | Issued |
Array
(
[id] => 17783500
[patent_doc_number] => 11406602
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof
[patent_app_type] => utility
[patent_app_number] => 16/826501
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7146
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16826501
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/826501 | Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof | Mar 22, 2020 | Issued |